FDA Forces Bextra Recall

On April 7, 2005, more than six months after Bextra (valdecoxib) came under public scrutiny for reported links to heart attacks and strokes, the FDA finally pressured Pfizer to issue a recall of Bextra. The agency still has not removed Celebrex from the market, but announced today that Celebrex will carry the strongest available warning for side effects. IF you’ve been affected…

Take action now! Contact Stenger Law Firm